Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL56309 | 0.78 | ALDH1A1 (0.35) | NPSR1KDM4EALDH1A1SIGMAR1HSD17B10 | |
| Ether SCHEMBL28087840 | 0.77 | THRB (0.38) | SHBGNPSR1THRBATML3MBTL1 | |
| SCHEMBL17041908 | 0.73 | ALDH1A1 (0.47) | EPHX1KDM4EALDH1A1SIGMAR1HSD17B10 | |
| SCHEMBL17046101 | 0.73 | ALDH1A1 (0.47) | EPHX1KDM4EALDH1A1SIGMAR1HSD17B10 | |
| SCHEMBL13166298 | 0.73 | ALDH1A1 (0.53) | EPHX1KDM4EALDH1A1SIGMAR1HSD17B10 | |
| SCHEMBL8918 | 0.73 | — | — | |
| SCHEMBL1148684 | 0.73 | — | — | |
| SCHEMBL3036481 | 0.73 | ALDH1A1 (0.53) | EPHX1KDM4EALDH1A1SIGMAR1HSD17B10 | |
| SCHEMBL3035987 | 0.73 | ALDH1A1 (0.53) | EPHX1KDM4EALDH1A1SIGMAR1HSD17B10 | |
| SCHEMBL13166302 | 0.73 | ALDH1A1 (0.53) | EPHX1KDM4EALDH1A1SIGMAR1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 500 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3081612-B1 | PHOTOCURABLE COMPOSITION HAVING ADHESIVE PROPERTIES | CEMEDINE CO LTD (JP) | 2018-11-14 | — | — | EP | claimed |
| US-8815985-B2 | Curable composition | KANEKA CORPORATION (JP) | 2014-08-26 | — | — | US | claimed |
| EP-4727982-A1 | PRIMER COMPOSITION, ADHESIVE SYSTEM, AND RELATED PROCESSES | 3M Innovative Properties Company (US) | 2026-04-22 | — | — | EP | disclosed |
| EP-3585851-B1 | AIR AND WATER BARRIER ARTICLE INCLUDING INELASTIC POROUS LAYER | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2026-04-01 | — | — | EP | disclosed |
| EP-4703405-A1 | CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12545691-B2 | Tertiary hydroxyl functional alkoxysilanes and methods for preparing thereof | HENKEL AG & CO. KGAA (DE) | 2026-02-10 | — | — | US | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4682204-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| EP-3929260-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2025-12-17 | — | — | EP | disclosed |
| EP-4656672-A1 | METHOD FOR PRODUCING CURABLE COMPOSITION | Kaneka Corporation (JP) | 2025-12-03 | — | — | EP | disclosed |
| EP-1746134-A1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746133-A1 | CURABLE COMPOSITION IMPROVED IN ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1736511-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-27 | — | — | EP | disclosed |
| EP-1734079-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | Kaneka Corporation (JP) | 2006-12-20 | — | — | EP | disclosed |
| EP-1731574-A1 | SINGLE-COMPONENT CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| EP-1731573-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2006-12-13 | — | — | EP | disclosed |
| US-20060252903-A1 | Curing composition | KANEKA CORPORATION | 2006-11-09 | — | — | US | disclosed |
| US-20060089432-A1 | Curable composition | KANEKA CORPORATION (JP) | 2006-04-27 | — | — | US | disclosed |
| EP-1624027-A1 | CURING COMPOSITION | KANEKA CORPORATION (JP) | 2006-02-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12545691-B2 | Tertiary hydroxyl functional alkoxysilanes and methods for preparing thereof | HCCS, EGLN1, RRS1 | SHBG 673/4885NPSR1 1391/4885THRB 285/4885 |
| US-20260022211-A1 | CURABLE COMPOSITION | H1-4, H1-0, H1-2 | SHBG 1856/4885NPSR1 4282/4885THRB 1451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.